AUG 11, 2020 6:51 AM PDT

Study Reveals the Two Sides of an Immune Molecule

WRITTEN BY: Tara Fernandez

Scientists have discovered a key protein that regulates the immune system to fight off infections. Fascinatingly, the protein called histone deacetylase 3, or HDAC3, plays seemingly contradictory roles in orchestrating the innate immune response, both initiating it as well as pumping the brakes to restore a state of equilibrium.

The study was published in the journal Nature and has important implications in how we can treat an array of inflammatory conditions beyond infection, including cancer. 

“Our work shows that HDAC3 is key to the innate immune response due to the yin and yang of its responsibilities – both triggering and reducing inflammation,” said senior author, Mitchell A. Lazar, from Penn Medicine. These results provide drug developers with a blueprint for designing precision medicines for countering potentially deadly inflammation.

Lazar and team used a suite of advanced genomic technologies to dissect the intricate function of HDAC3, which acts as an enzyme, catalyzing an array of different immune reactions. Interestingly, the scientists found that HDAC3 functioned much like a light switch. In the “on” position, the enzyme triggered inflammation, while in the “off” state, it repressed it.

 

 

The study’s lead author, Hoang C. B. Nguyen, suggests HDAC inhibitors currently in development for treating cancer and inflammation will have to be scrutinized as a result of this new information. “It has been the tradition to target the enzymatic functions of HDAC molecules for decades, but we want to bring attention to the non-enzymatic functions that should be targeted instead,” Nguyen said. 

“In the words of Confucius himself, who introduced the Yin and Yang system of philosophy, ‘Do not use a cannon to kill a mosquito,’ as it might do more damage than good.”

 

Source: Penn Medicine News, Nature.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
NOV 09, 2020
Drug Discovery & Development
COVID-19 Vaccine by Pfizer More than 90% Effective
NOV 09, 2020
COVID-19 Vaccine by Pfizer More than 90% Effective
A preliminary analysis of Pfizer and BioNTech's COVID-19 vaccine shows that it can prevent over 90% of people from c ...
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
DEC 10, 2020
Immunology
Drug Turns Back the Clock in Aged Brains
DEC 10, 2020
Drug Turns Back the Clock in Aged Brains
When faced with stressful stimuli — anything from oxygen or nutrient deprivation to viral infections — cells ...
DEC 07, 2020
Cell & Molecular Biology
An Autoimmune Link to Heart Disease is ID'ed
DEC 07, 2020
An Autoimmune Link to Heart Disease is ID'ed
CNIC researchers have found that there is an autoimmune link to cardiovascular disease that may improve diagnostic and t ...
DEC 25, 2020
Immunology
A High-Fat Diet Starves Immune Cells, Tumor Growth Goes Unchecked
DEC 25, 2020
A High-Fat Diet Starves Immune Cells, Tumor Growth Goes Unchecked
  Sitting down to enjoy an indulgent Christmas feast? A recent study in mice by Harvard Medicine scientists found t ...
DEC 27, 2020
Microbiology
A Potential Treatment Approach for Crohn's Disease
DEC 27, 2020
A Potential Treatment Approach for Crohn's Disease
Researchers may have found a way to treat or prevent Crohn's disease, one of the most common forms of inflammatory bowel ...
Loading Comments...